Literature DB >> 8057495

Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.

A Rein1, D P Harvin, J Mirro, S M Ernst, R J Gorelick.   

Abstract

We have analyzed RNA packaging by a series of mutants altered in the nucleocapsid (NC) protein of Moloney murine leukemia virus (Mo-MuLV). We found that mutants lacking residues 8 through 11 or 44 through 60 of NC package Mo-MuLV RNA with virtually the same efficiency as wild-type Mo-MuLV. In contrast, point mutants altered at the conserved cysteines in the cysteine array (residues 26 and 29) and a mutant lacking residues 16 through 23 packaged Mo-MuLV RNA with approximately 1% of the efficiency of wild-type Mo-MuLV. The deficiency in packaged RNA was observed not only in Northern (RNA) analysis but also in an RNA-PCR assay, which would detect degraded as well as intact RNA. One of the cysteine array mutants was also shown to be defective with respect to encapsidation of hygromycin phosphotransferase mRNA containing a Mo-MuLV packaging signal. We suggest that a central region of NC, consisting of the cysteine array and flanking basic residues, is required for RNA packaging in Mo-MuLV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057495      PMCID: PMC237026     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Retroviral RNA packaging: sequence requirements and implications.

Authors:  M L Linial; A D Miller
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

Authors:  R J Gorelick; S M Nigida; J W Bess; L O Arthur; L E Henderson; A Rein
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

5.  Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.

Authors:  C Méric; S P Goff
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.

Authors:  J L Darlix; C Gabus; M T Nugeyre; F Clavel; F Barré-Sinoussi
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

7.  cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA.

Authors:  A C Prats; C Roy; P A Wang; M Erard; V Housset; C Gabus; C Paoletti; J L Darlix
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein.

Authors:  P Dupraz; S Oertle; C Meric; P Damay; P F Spahr
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.

Authors:  R D Berkowitz; J Luban; S P Goff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA.

Authors:  A C Prats; L Sarih; C Gabus; S Litvak; G Keith; J L Darlix
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  46 in total

1.  RNA is a structural element in retrovirus particles.

Authors:  D Muriaux; J Mirro; D Harvin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

Authors:  J Gonsky; E Bacharach; S P Goff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.

Authors:  I A Topol; C McGrath; E Chertova; C Dasenbrock; W R Lacourse; M A Eissenstat; S K Burt; L E Henderson; J R Casas-Finet
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

5.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.

Authors:  Shainn-Wei Wang; Anna Aldovini
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome.

Authors:  Cristina Gherghe; Tania Lombo; Christopher W Leonard; Siddhartha A K Datta; Julian W Bess; Robert J Gorelick; Alan Rein; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

8.  A small region of the ecotropic murine leukemia virus (MuLV) gag gene profoundly influences the types of polytropic MuLVs generated in mice.

Authors:  M Lavignon; J Richardson; L H Evans
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 9.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

10.  Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA.

Authors:  J L Certo; B F Shook; P D Yin; J T Snider; W S Hu
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.